These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


98 related items for PubMed ID: 16098921

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K, Wand H, Law M, Emery S, Cooper D, Carr A.
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [Abstract] [Full Text] [Related]

  • 23. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project.
    Ferreira I, Boreham CA, Twisk JW, Gallagher AM, Young IS, Murray LJ, Stehouwer CD.
    J Hypertens; 2007 May; 25(5):1009-20. PubMed ID: 17414665
    [Abstract] [Full Text] [Related]

  • 24. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A, Hergenç G, Türkmen S, Yazici M, Sari I, Can G.
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [Abstract] [Full Text] [Related]

  • 25. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study.
    Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ, Jansen EH, Schalkwijk CG, Stehouwer CD.
    Eur J Clin Invest; 2009 Jun; 39(6):437-44. PubMed ID: 19397692
    [Abstract] [Full Text] [Related]

  • 26. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
    Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Walldius G, Hamsten A, Hellénius ML, Fisher RM.
    Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
    [Abstract] [Full Text] [Related]

  • 27. Associations of metabolic syndrome with inflammation in CKD: results From the Third National Health and Nutrition Examination Survey (NHANES III).
    Beddhu S, Kimmel PL, Ramkumar N, Cheung AK.
    Am J Kidney Dis; 2005 Oct; 46(4):577-86. PubMed ID: 16183411
    [Abstract] [Full Text] [Related]

  • 28. The appearance of aggregated erythrocytes in the peripheral blood of individuals with insulin resistance.
    Justo D, Marilus R, Mardi T, Tolchinsky T, Goldin Y, Rozenblat M, Rogowski O, Yerushalmi Y, Stern N, Shenkerman G, Deutsch V, Zeltser D, Berliner S, Shapira I.
    Diabetes Metab Res Rev; 2003 Oct; 19(5):386-91. PubMed ID: 12951646
    [Abstract] [Full Text] [Related]

  • 29. Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation.
    Berliner S, Shapira I, Toker S, Melamed S, Shirom A, Rogowski O.
    Blood Cells Mol Dis; 2005 Oct; 34(2):135-40. PubMed ID: 15727895
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L.
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D.
    Int J Cardiol; 2007 Oct 18; 121(3):229-38. PubMed ID: 17368586
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
    Strazzullo P, Barbato A, Siani A, Cappuccio FP, Versiero M, Schiattarella P, Russo O, Avallone S, della Valle E, Farinaro E.
    Metabolism; 2008 Mar 18; 57(3):355-61. PubMed ID: 18249207
    [Abstract] [Full Text] [Related]

  • 39. High-sensitivity C-reactive protein and the hypertriglyceridemic waist in patients with type 2 diabetes and metabolic syndrome.
    Rosolova H, Petrlova B, Simon J, Sifalda P, Sipova I.
    Med Sci Monit; 2008 Aug 18; 14(8):CR411-5. PubMed ID: 18667998
    [Abstract] [Full Text] [Related]

  • 40. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
    Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.
    Int J Obes (Lond); 2007 Feb 18; 31(2):213-20. PubMed ID: 16755284
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.